The court ordered the molecular diagnostic company to stop offering the Fetalis test it started offering in Germany this summer, which is based on Ariosa's technology.
Through Navican, patients at Intermountain can get tested on an internally developed NGS platform that gauges a range of actionable genes implicated in cancer.
Researchers have developed a positional mapping approach to be used in conjunction with exome sequencing to limit the search for causative variants.
The first apps will be for individuals at low risk for inherited forms of cancer and heart disease, and will require a doctor's permission.
The researchers hope that unbiased sequencing will improve their ability to identify infections caused by knee and hip replacements.
In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.
A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.
Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.
Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.